New York Times
ORLANDO, Fla. In a finding that is likely to shake up medical practice, researchers reported here that early detection of a relapse of ovarian cancer with a widely used blood test does not help women live longer.
The finding goes against the common presumption that early detection and treatment of cancer is better. It could force doctors and patients to re-evaluate the need for the periodic testing that has become an anxiety-inducing but also reassuring ritual for many women who have had ovarian cancer... Read More